Transvenous pacemaker lead extraction in infective endocarditis

Inhibition Effects of Oncological Drugs for Treatment of Cancer, on Paraoxonase-1 Enzyme (PON1) Activity and Cardiovascular Toxicity

“…One of the most important side effects of cancer chemotherapy is cardiovascular toxicity [3][4][5] . Advances in cancer knowledge and treatment have led to a new field called cardiovascular oncology 6,7 . Trastuzumab (Herceptin, Genentech Inc., South San Francisco, CA, USA) is a monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) 8 .…”

Cardiac rehabilitation in pacing patient complications: an increasing scenario requiring a collaborative vision of a multi-disciplinary treatment team

“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to the delivery of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27]. Infectious complications leading also to endocarditis [1,8,[28][29][30][31][32][33][34][35][36] and non-infectious complications [9,21,23,[37][38][39][40] often necessitating removal [1,2,8,[40][41][42][43][44][45][46] affect patients' wellbeing also leading to psychological difficulties increase [47][48][49][50][51][52][53] in the emerging scenario of concomitant problems and diseases and in patients also needing of device revision and upgrade. Moreover, the modern ICDs in the market deliver maximum energy of 35 to 41 J in relation to the model using single-coil leads or dual-coil leads.…”

Cardiac rehabilitation in pacing venous occlusions

“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to delivery of pacemakers, implantable cardioverter defibrillators (ICD)s and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27] and subcutaneous single-finger cardioverter-defibrillator (ICD) system [28]. Infectious complications leading also to endocarditis [1,8,[29][30][31][32][33][34][35][36][37] and non-infectious complications [9,21,23,[38][39][40][41] often necessitating removal [1,2,8,[41][42][43][44][45][46][47] affect patients' wellbeing which also leads to psychological difficulty increase [48][49][50][51][52][53][54] in the emerging scenario of concomitant problems and diseases and in patients that also need device revision and upgrade. In addition, the improved patients' survival, the progressively younger implanted population and the increase in device and procedur...…”